Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52,265,866
-
Total 13F shares
-
21,913,377
-
Share change
-
+1,264,265
-
Total reported value
-
$98,615,619
-
Put/Call ratio
-
186%
-
Price per share
-
$4.50
-
Number of holders
-
82
-
Value change
-
+$6,206,696
-
Number of buys
-
39
-
Number of sells
-
28
Institutional Holders of ENZO BIOCHEM INC - Common Stock (ENZB) as of Q4 2015
As of 31 Dec 2015,
ENZO BIOCHEM INC - Common Stock (ENZB) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,913,377 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, First Light Asset Management, LLC, DIMENSIONAL FUND ADVISORS LP, GRANAHAN INVESTMENT MANAGEMENT INC/MA, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Institutional Trust Company, N.A., MANUFACTURERS LIFE INSURANCE COMPANY, THE, UBS ASSET MANAGEMENT AMERICAS INC, and Lone Star Value Management LLC.
This page lists
82
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.